Associations with smoking and shared epitope differ between IgA- and IgG-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis

Arthritis and Rheumatology

Volumn 67, Issue 8, 2015, Pages 2032-2037

  Svärd, Anna ^a   Skogh, Thomas ^a   Alfredsson, Lars ^b   Ilar, Anna ^c   Klareskog, Lars ^b   Bengtsson, Camilla ^c   Kastbom, Alf ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b STOCKHOLM COUNTY COUNCIL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; EPITOPE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; SHARED EPITOPE; UNCLASSIFIED DRUG; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ALLELE; ANTIBODY BLOOD LEVEL; ARTICLE; ATTRIBUTABLE RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY INTERVENTION; FEMALE; HISTOPATHOLOGY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SEROLOGY; SMOKING; SMOKING HABIT; GENETICS; GENOTYPE; IMMUNOLOGY;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; COHORT STUDIES; EPITOPES; FEMALE; GENOTYPE; HLA-DRB1 CHAINS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; SMOKING;

EID: 84938085267     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39170     Document Type: Article

References (34)

1. Costenbader KH, Feskanich D, Mandl LA, Karlson EW., Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med 2006; 119: 503.e1-9.
2. Bergstrom U, Jacobsson LT, Nilsson JA, Wirfalt E, Turesson C., Smoking, low formal level of education, alcohol consumption, and the risk of rheumatoid arthritis. Scand J Rheumatol 2013; 42: 123-30.
3. Di Giuseppe D, Discacciati A, Orsini N, Wolk A., Cigarette smoking and risk of rheumatoid arthritis: a dose-response meta-analysis. Arthritis Res Ther 2014; 16: R61.
4. Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, et al., and the Epidemiological Investigation of Rheumatoid Arthritis Study Group. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54: 38-46.
5. McInnes IB, Schett G., The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365: 2205-19.
6. Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA, Kloppenburg M, de Vries RR, le Cessie S, et al., Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis 2006; 65: 366-71.
7. Reynisdottir G, Karimi R, Joshua V, Olsen H, Hensvold AH, Harju A, et al., Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol 2014; 66: 31-9.
8. Demoruelle MK, Weisman MH, Simonian PL, Lynch DA, Sachs PB, Pedraza IF, et al., Airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 2012; 64: 1756-61.
9. Makrygiannakis D, Hermansson M, Ulfgren AK, Nicholas AP, Zendman AJ, Eklund A, et al., Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008; 67: 1488-92.
10. Klareskog L, Ronnelid J, Lundberg K, Padyukov L, Alfredsson L., Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 2008; 26: 651-75.
11. Verpoort KN, Jol-van der Zijde CM, Papendrecht-van der Voort EA, Ioan-Facsinay A, Drijfhout JW, van Tol MJ, et al., Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum 2006; 54: 3799-808.
12. Svard A, Kastbom A, Reckner-Olsson A, Skogh T., Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project. Arthritis Res Ther 2008; 10: R75.
13. Svard A, Kastbom A, Soderlin MK, Reckner-Olsson A, Skogh T., A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis. J Rheumatol 2011; 38: 1265-72.
14. Kokkonen H, Mullazehi M, Berglin E, Hallmans G, Wadell G, Rönnelid J, et al., Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis. Arthritis Res Ther 2011; 13: R13.
15. Willis VC, Demoruelle MK, Derber LA, Chartier-Logan CJ, Parish MC, Pedraza IF, et al., Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. Arthritis Rheum 2013; 65: 2545-54.
16. Svard A, Kastbom A, Sommarin Y, Skogh T., Salivary IgA antibodies to cyclic citrullinated peptides (CCP) in rheumatoid arthritis. Immunobiology 2013; 218: 232-7.
17. Willemze A, Shi J, Mulder M, Stoeken-Rijsbergen G, Drijfhout JW, Huizinga TW, et al., The concentration of anticitrullinated protein antibodies in serum and synovial fluid in relation to total immunoglobulin concentrations. Ann Rheum Dis 2013; 72: 1059-63.
18. Verpoort KN, Papendrecht-van der Voort EA, van der Helm-van Mil AH, Jol-van der Zijde CM, van Tol MJ, Drijfhout JW, et al., Association of smoking with the constitution of the anti-cyclic citrullinated peptide response in the absence of HLA-DRB1 shared epitope alleles. Arthritis Rheum 2007; 56: 2913-8.
19. Kastbom A, Strandberg G, Lindroos A, Skogh T., Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 2004; 63: 1085-9.
20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
21. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L, for the Epidemiological Investigation of Rheumatoid Arthritis Study Group. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004; 50: 3085-92.
22. Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, et al., Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003; 62: 835-41.
23. Rothman KJ, Greenland S, Lash TL., Measures of effect and measures of association. In: Modern epidemiology. 3rd ed. Philadelphia: Lippincott-Raven, Publishers; 2008. p. 51-70.
24. Knol MJ, VanderWeele TJ, Groenwold RH, Klungel OH, Rovers MM, Grobbee DE., Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol 2011; 26: 433-8.
25. De Fijter JW, Eijgenraam JW, Braam CA, Holmgren J, Daha MR, van Es LA, et al., Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int 1996; 50: 952-61.
26. Bergquist C, Johansson EL, Lagergard T, Holmgren J, Rudin A., Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun 1997; 65: 2676-84.
27. Schuyler M, Lyons CR, Masten B, Bice D., Immunoglobulin response to intrapulmonary immunization of asthmatics. Immunology 1997; 91: 167-75.
28. Otten HG, Daha MR, van der Maarl MG, Hoogendoorn LI, Beem EM, de Rooy HH, et al., IgA rheumatoid factor in mucosal fluids and serum of patients with rheumatoid arthritis: immunological aspects and clinical significance. Clin Exp Immunol 1992; 90: 256-9.
29. Mahdi H, Fisher BA, Kallberg H, Plant D, Malmstrom V, Ronnelid J, et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated α-enolase in the etiology of rheumatoid arthritis. Nat Genet 2009; 41: 1319-24.
30. Van der Woude D, Alemayehu WG, Verduijn W, de Vries RR, Houwing-Duistermaat JJ, Huizinga TW, et al., Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis. Nat Genet 2010; 42: 814-6.
31. Lundberg K, Bengtsson C, Kharlamova N, Reed E, Jiang X, Kallberg H, et al., Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile. Ann Rheum Dis 2013; 72: 652-8.
32. Snir O, Widhe M, von Spee C, Lindberg J, Padyukov L, Lundberg K, et al., Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann Rheum Dis 2009; 68: 736-43.
33. Chandra PE, Sokolove J, Hipp BG, Lindstrom TM, Elder JT, Reveille JD, et al., Novel multiplex technology for diagnostic characterization of rheumatoid arthritis. Arthritis Res Ther 2011; 13: R102.
34. Hansson M, Mathsson L, Schlederer T, Israelsson L, Matsson P, Nogueira L, et al., Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides. Arthritis Res Ther 2012; 14: R201.